Pentagalloylglucose down-regulates mast cell surface FcεRI expression in vitro and in vivo

被引：32

作者：

Kageyama-Yahara, Natsuko ^{[1
]}

Suehiro, Yoko ^{[1
]}

Maeda, Futoshi ^{[1
]}

Kageyama, Shun-ichiro ^{[2
]}

Fukuoka, Junya ^{[2
]}

Katagiri, Tatsuo ^{[3
]}

Yamamoto, Takeshi ^{[1
]}

Kadowaki, Makoto ^{[1
]}

机构：

[1] Toyama Univ, Inst Nat Med, Dept Biosci, Div Gastrointestinal Pathophysiol, Toyama 9300194, Japan

[2] Toyama Univ Hosp, Pathol Lab, Toyama, Japan

[3] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Biol, Toyama 9300194, Japan

来源：

FEBS LETTERS | 2010年 / 584卷 / 01期

关键词：

Mast cell; Gene expression; Allergy; FOOD ALLERGY; IGE ANTIBODY; KAPPA-B; RELEASE; GROWTH; DIFFERENTIATION; HETEROGENEITY; HOMEOSTASIS; CYTOKINES; DIARRHEA;

D O I：

10.1016/j.febslet.2009.11.007

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Mast cell activation by immunoglobulin E (IgE)-mediated stimuli is a central event in the pathogenesis of allergic disorders. The present report shows that treatment with pentagalloylglucose (PGG) resulted in a down-regulation of FceRI surface expression on mucosal-type murine bone marrow-derived mast cells (mBMMCs), which correlated with a reduction in IgE-mediated activation of mBMMCs. Furthermore, PGG prevented development of allergic diarrhea in a food-allergy mouse model and suppressed the up-regulated FceRI surface expression on mast cells derived from the food-allergy mouse colon. These findings on PGG suggest its therapeutic potential for allergic diseases through suppressing the FceRI surface expression. (C) 2009 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.

引用

页码：111 / 118

页数：8

共 23 条

[1] The biology of stem cell factor and its receptor C-kit [J].

Ashman, LK .

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1999, 31 (10) :1037-1051

[2] Omalizumab-induced reductions in mast cell FcεRI expression and function [J].

Beck, LA ;

Marcotte, GV ;

MacGlashan, D ;

Togias, A ;

Saini, S .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 114 (03) :527-530

[3] MAST-CELL HETEROGENEITY - DERIVATION AND FUNCTION, WITH EMPHASIS ON THE INTESTINE [J].

BIENENSTOCK, J ;

BEFUS, AD ;

PEARCE, F ;

DENBURG, J ;

GOODACRE, R .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1982, 70 (06) :407-412

[4]

Brandt EB, 2003, J CLIN INVEST, V112, P1666, DOI 10.1172/JCI19785

[5] CALCIUM IONOPHORES AND MOVEMENT OF CALCIUM-IONS FOLLOWING PHYSIOLOGICAL STIMULUS TO A SECRETORY PROCESS [J].

FOREMAN, JC ;

MONGAR, JL ;

GOMPERTS, BD .

NATURE, 1973, 245 (5423) :249-251

[6]

GALLI SJ, 1990, LAB INVEST, V62, P5

[7] Mast cell growth, differentiation, and death [J].

Gurish, MF ;

Boyce, JA .

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2002, 22 (02) :107-118

[8] EFFECT OF ANTIANAPHYLACTIC AGENTS ON SUBSTANCE-P INDUCED HISTAMINE-RELEASE FROM RAT PERITONEAL MAST-CELLS [J].

HACHISUKA, H ;

NOMURA, H ;

SAKAMOTO, F ;

MORI, O ;

OKUBO, K ;

SASAI, Y .

ARCHIVES OF DERMATOLOGICAL RESEARCH, 1988, 280 (03) :158-162

[9] IgE antibody up-regulates high affinity IgE binding on murine bone marrow-derived mast cells [J].

Hsu, C ;

MacGlashan, D .

IMMUNOLOGY LETTERS, 1996, 52 (2-3) :129-134

[10] IgE-induced degranulation of mucosal mast cells is negatively regulated via nicotinic acetylcholine receptors [J].

Kageyama-Yahara, Natsuko ;

Suehiro, Yoko ;

Yamamoto, Takeshi ;

Kadowaki, Makoto .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 377 (01) :321-325

← 1 2 3 →